Insider sale
RETINALGENIX TECHNOLOGIES INC.
$31.6K
10K shares
What this filing means
BAYERN STEVEN plans to sell 10K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $31.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/5/2024ACC: 0001959173-24-000706
10K
Shares to sell
$31.6K
Approx. market value
100K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Warrant Exercise
Cash/ check
3/26/2019
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2019 | Warrant Exercise Cash/ check | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
100.00
Market value
$310.00
1/10/2024
—Completed
Units to sell
200.00
Market value
$618.00
11/7/2023
Planned — Approximate Date
OTCPlanned
Units to sell
9.70K
Market value
$30.7K
2/5/2024
Total
Units
10K
Value
$31.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/10/2024 | 100.00 | $310.00 | — | Completed |
11/7/2023 | 200.00 | $618.00 | — | Completed |
| Planned — Approximate Date | ||||
2/5/2024 | 9.70K | $30.7K | OTC | Planned |
| Total | 10K | $31.6K | ||